SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BROOKS LABORATORIES

BSE: 533543 01 Jun 2025
Healthcare
₹ 136.65
BROOKS LABORATORIES LIMITED specializes in Pharmaceuticals within the Healthcare sector.

BROOKS LABORATORIES - Share Price & Details

Market Cap
₹422.0
High /Low
203.0 / 72.5
Stock P/E
138.0
Book Value
₹39.1
Dividend Yield
0.0
ROCE
4.31
ROE
₹3.3
Face Value
10.0
PEG Ratio
8.47
EVEBITDA
₹73.1
Debt
7.58
CMP / FCF
-62.9
Debt to equity
₹0.07
NP Ann
3.05
High price all time
203.0
Piotroski score
₹6.0
Graham Number
30.2
No. Eq. Shares
2.95
Net CF
₹0.10
Net profit
3.05
Price to book value
3.67
Interest Coverage
₹4.14
Low price all time
10.3
Industry PE
33.5
Reserves
₹85.6
Free Cash Flow
₹-10.1

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and ServicNANANANA4.6330.9
Triochem Products Ltd.,NANANANA0
BROOKS LABORATORIES LTD.NANANANA422.0138.0
EVEREST ORGANICS LTD.NANANANA414
SMS Lifesciences India LtdNANANANA39621.1

Peer Comparison Chart


About BROOKS LABORATORIES

BROOKS LABORATORIES LIMITED, with Security Code 533543, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Brooks Laboratories reports consolidated net loss of Rs 1.46 crore in the March 2025 quarter

(29 May 2025)
Sales rise 31.60% to Rs 23.32 crore. Net Loss of Brooks Laboratories reported to Rs 1.46 crore in the quarter ended March 2025 as against net loss of Rs...
Read more →

Brooks Laboratories Faces Mixed Technical Signals Amid Declining Profits and Increased Investor Interest

(29 May 2025)
Brooks Laboratories has recently adjusted its evaluation score, indicating a shift in its technical trend. Despite a strong annual return of 53.03%,...
Read more →

Brooks Laboratories Faces Financial Challenges Amid Rising Institutional Investor Interest

(20 May 2025)
Brooks Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, recently experienced a score adjustment amid mixed financial...
Read more →

Brooks Laboratories Faces Evaluation Shift Amid Mixed Technical Signals and Fundamental Challenges

(02 May 2025)
Brooks Laboratories has recently experienced a change in its evaluation, influenced by mixed technical indicators.
Read more →

Brooks Laboratories to declare Quarterly Results

(01 May 2025)
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2025.
Read more →

Mutual Funds increased stake in 14 pharma stocks in Q4FY25; do you own any?

(01 May 2025)
Mutual Funds Stake in Pharma Stocks: Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for...
Read more →